Summary

The development of fetal monitoring technologies is a critical component of the ongoing evolution of the healthcare sector in North America. During pregnancy and childbirth, fetal monitoring devices are essential for the health and safety of the mother and the fetus. A growing emphasis on maternal and fetal health, along with technological improvements, has led to tremendous growth and innovation in this market area throughout the years. The market for fetal monitoring equipment in North America has grown rapidly, mostly due to a rise in high-risk pregnancies, growing maternal ages, and growing knowledge of prenatal care. The increasing occurrence of lifestyle-related illnesses, including obesity and diabetes, in expectant mothers has further highlighted the necessity for sophisticated fetal monitoring systems. There have been notable technological developments in fetal monitoring equipment in recent years. Fetal echocardiography and electronic fetal monitoring (EFM) are two examples of more advanced and precise technologies that have replaced more conventional techniques, such as external monitoring using Doppler ultrasound equipment. These technologies provide real-time monitoring, which helps medical personnel identify and quickly handle any possible problems. North America, which consists of the United States and Canada as the main market contributors, has distinct patterns. Due to its strong healthcare system and large R&D expenditures, the U.S. market in particular continues to be a major contributor to innovation. In contrast, Canada is demonstrating a rise in the need for sophisticated fetal monitoring equipment due to public health campaigns and rising awareness. Fetal monitoring devices are expected to see considerable growth in the North American market as the importance of mother and fetal health continues to rise. Prenatal care could be revolutionized by the incorporation of artificial intelligence (AI) and machine learning (ML) into these devices, which could lead to more precise and proactive monitoring. Furthermore, the move to remote monitoring options might create new opportunities that would make pregnancies in underserved or rural locations more convenient and accessible.

According to the research report "North America Fetal Monitoring Devices Market Outlook, 2028," published by Bonafide Research, the North America Fetal Monitoring Devices market is anticipated to add more than USD 500 Million from 2023 to 2028. The region is a hub for scientific research and technological advancement. North America consistently promotes the development of healthcare technologies through significant investments in research and development. This propensity for innovation propels the creation of advanced fetal monitoring equipment with improved features, including connectivity, data analytics, and real-time monitoring. Medical device safety and efficacy are guaranteed by North America's strict regulatory standards. Fetal monitoring device clearance and marketing are subject to strict regulations set by Health Canada in Canada and the Food and Drug Administration (FDA) in the United States. Strict testing and validation are required due to the strict regulatory environment, guaranteeing that only dependable and superior equipment is released onto the market. The customers in the region are very aware of healthcare issues, including prenatal care. Expectant moms are more proactive and knowledgeable about both their own and their unborn child's health. Fetal monitoring gadget sales are being driven by the increased demand for cutting-edge prenatal care technology as a result of this increased awareness. North American populations are diverse and have a range of healthcare demands. A variety of socioeconomic backgrounds, health difficulties associated with lifestyle choices and motherhood all contribute to a varied market environment. Due to this variability, there is a need for a broad variety of fetal monitoring equipment that may meet various healthcare needs and budgetary constraints.

Based on report market is divided into three major countries, United States, Canada, and Mexico. Among them United States accounted for the largest market for fetal monitoring devices in North America.

The extensive use of fetal monitoring procedures is encouraged by the state-of-the-art healthcare infrastructure in the United States, which includes well-equipped institutions. The Centers for Disease Control and Prevention (CDC) estimate that 2% to 10% of pregnancies in the US are affected by gestational diabetes annually. Fetal monitoring technologies are becoming more important in the fight against the potential risks and consequences of gestational diabetes, which is becoming more common in the US. In addition, the US continues to be a pioneer in technology, developing and implementing state-of-the-art methods and technologies for fetal monitoring. Moreover, continuous R&D initiatives foster innovation in the field and universal health insurance coverage pushes expectant mothers to give regulated prenatal care and fetal monitoring first priority. The innovation landscape for medical technology is robust in the United States. Businesses are always pushing the boundaries of technology in an effort to enhance fetal monitoring systems use, accuracy, and reliability. This focus on innovation also encourages corporate competition, creating a climate that fosters rapid and ongoing development. The need for fetal monitoring devices is influenced by the sheer size and diversity of the US population. A growing number of high-risk births, an aging population, and a growth in motherhood are driving the market for these devices.

Based on product segment market is segmented into ultrasound devices, electronic maternal/fetal monitors, uterine contraction monitor, fetal electrodes, fetal doppler devices, telemetry devices, accessories and consumables and other products. Among them market is majorly dominated by ultrasound devices product type.

Healthcare professionals favor ultrasound devices because of their non-invasiveness and safety for the mother and the fetus. The fetus may be imaged in real time thanks to this technology, which makes it possible to track its growth and health in great detail during the pregnancy. This capacity is essential for seeing possible issues early on and allowing for prompt measures to protect the health of the mother and the fetus. Furthermore, ultrasound equipment is adaptable, giving a range of modes, including 2D, 3D, and 4D imaging, which provides thorough insights into the anatomy and physiology of the fetus. This adaptability enables medical practitioners to do a comprehensive examination, assisting in the identification of anomalies or problems that may develop throughout pregnancy. The ongoing developments in ultrasound technology also play a role in their dominance. The incorporation of elements like Doppler ultrasound, which permits the monitoring of blood flow in the fetus and the placenta, is the result of ongoing research and development activities. Furthermore, the advent of portable and handheld ultrasound devices, as well as advancements in picture resolution, have increased the devices' usefulness and accessibility in a variety of healthcare settings.

Based on application segment market includes antepartum fetal monitoring and intrapartum fetal monitoring. Antepartum fetal monitoring application is predicted to lead the market of North America. Based on end user segment market is divided into hospitals, obstetrics and gynecology clinics and home care settings.

Antepartum fetal monitoring, which includes a variety of methods intended to evaluate fetal health during pregnancy, is the term used to describe the monitoring of the fetus prior to birth. Due to its critical role in the early identification and treatment of possible difficulties, this kind of monitoring has become more popular, improving the outcomes of pregnancies in the process. Early identification of fetal anomalies, developmental limitations, or discomfort is made possible by antepartum surveillance. By taking a proactive stance, healthcare providers can respond quickly to reduce risks to the mother and the fetus by carrying out the required measures. Comprehensive prenatal care is becoming more and more important, with frequent monitoring and evaluation encouraged throughout the pregnancy. This paradigm is supported by antepartum fetal monitoring, which offers a way to monitor fetal health and guarantees a continuum of care from conception to delivery. Comprehensive obstetric units and neonatal care facilities are features seen in hospitals. They are the main hubs for fetal monitoring because they handle a substantial percentage of births and pregnancies. They are more dependent on fetal monitoring technologies to protect the health of both the mother and the fetus since they have the infrastructure to handle varying degrees of pregnancy complications. Hospitals are prepared to address urgent conditions and crises related to childbirth. In order to prevent negative consequences for both the mother and the baby, fetal monitoring devices are essential for keeping an eye on any fetal distress or difficulties throughout delivery.

Companies Covered in this report:

GE HealthCare Technologies, Inc., Siemens Healthineers, Koninklijke Philips N.V., Mindray Medical International Limited, Canon Medical Systems Corporation, Samsung Medison Co., Ltd, Esaote SpA, Cardinal Health, Inc., Edan Instruments, Inc., Natus Medical Incorporated, The Cooper Companies, Inc., Becton, Dickinson and Company.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Fetal Monitoring Devices market Outlook with its value and forecast along with its segments
• Country-wise Fetal Monitoring Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product:

• Ultrasound Devices
• Electronic Maternal/Fetal Monitors
• Uterine Contraction Monitor
• Fetal Electrodes
• Fetal Doppler Devices
• Telemetry Devices
• Accessories and Consumables
• Other Products

By Application:

• Antepartum Fetal Monitoring
• Intrapartum Fetal Monitoring

By End User:

• Hospitals
• Obstetrics and Gynecology Clinics
• Home Care Settings

By Indication:

• Pregnancy
• Diabetes
• Cardiovascular Disorders & Hypertension
• Respiratory Diseases
• Movement Disorders
• Other Indications

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Fetal Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents